Gene symbol	Chromosomal location	Gene name	Cell line	Fold change
211456_x_at	1q43	Similar to 60S ribosomal protein L35	MM1	6.6
211781_x_at	NA	NA	U266	11.6
213685_at	NA	Gene from PAC 886K2, chromosome 1	NCI-H929	6.2
215594_at	NA	PTR7 mRNA for repetitive sequence	NCI-H929	7.7
222296_at	NA	Transcribed locus, weakly similar to XP_371797.1 PREDICTED: hypothetical protein XP_371797 [Homo sapiens]	U266	19.3
222315_at	NA	Transcribed locus	U266	7.6
AASS	7q31.3	aminoadipate-semialdehyde synthase	U266, NCI-H929	24.6, 9.6
ABAT	16p13.2	4-aminobutyrate aminotransferase	MM1, U266, NCI-H929	8.3, 122.8, 11.0
ABCB1	7q21.1	ATP-binding cassette, sub-family B (MDR/TAP), member 1	NCI-H929	18.1
ABHD5	3p21	abhydrolase domain containing 5	NCI-H929	10.6
ABTB2	11p13	ankyrin repeat and BTB (POZ) domain containing 2	U266	7.5
ACADSB	10q25-q26	acyl-Coenzyme A dehydrogenase, short/branched chain	U266	4.9
ACSL3	2q34-q35	acyl-CoA synthetase long-chain family member 3	U266	4.4
ADARB1	21q22.3	adenosine deaminase, RNA-specific, B1 (RED1 homolog rat)	U266	59.4
ADCY9	16p13.3	adenylate cyclase 9	U266	28.4
AGRN	1p36.33	agrin	MM1, U266, NCI-H929	5.2, 12.0, 13.4
AHR	7p15	aryl hydrocarbon receptor	MM1	6.5
AKAP12	6q24-q25	A kinase (PRKA) anchor protein (gravin) 12	MM1, U266, NCI-H929	11.2, 44.8, 12.6
AKAP13	15q24-q25	A kinase (PRKA) anchor protein 13	NCI-H929	4.6
AKR1C3	10p15-p14	aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)	U266	15.9
ALCAM	3q13.1	activated leukocyte cell adhesion molecule	NCI-H929	19.5
ALDH1A3	15q26.3	aldehyde dehydrogenase 1 family, member A3	U266	9.9
ALDH2	12q24.2	aldehyde dehydrogenase 2 family (mitochondrial)	NCI-H929	4.8
ALDH4A1	1p36	aldehyde dehydrogenase 4 family, member A1	U266	8.2
ALDOC	17cen-q12	aldolase C, fructose-bisphosphate	MM1, NCI-H929	6.6, 9.2
ALPP	2q37	alkaline phosphatase, placental (Regan isozyme)	U266	11.5
ALPPL2	2q37	alkaline phosphatase, placental-like 2	U266	37.6
ANKRD6	6q14.2-q16.1	ankyrin repeat domain 6	U266	11.9
APG12L	5q21-q22	APG12 autophagy 12-like (S. cerevisiae)	U266	8.2
APLP1	19q13.1	amyloid beta (A4) precursor-like protein 1	MM1, U266	24.9, 25.3
APLP2	11q23-q25|11q24	amyloid beta (A4) precursor-like protein 2	MM1, U266	7.7, 5.0
APOE	19q13.2	apolipoprotein E	U266, NCI-H929	43.6, 41.4
AREG	4q13-q21	amphiregulin (schwannoma-derived growth factor)	NCI-H929	9.3
ARG2	14q24.1-q24.3	arginase, type II	NCI-H929	104.3
ARL6IP	16p12-p11.2	ADP-ribosylation factor-like 6 interacting protein	MM1	5.4
ARMCX2	Xq21.33-q22.2	armadillo repeat containing, X-linked 2	U266	7.5
ASMTL	Xp22.3; Yp11.3	acetylserotonin O-methyltransferase-like	U266	7.1
ATF7IP2	16p13.13	activating transcription factor 7 interacting protein 2	MM1	10
ATP13A2	1p36	ATPase type 13A2	MM1	37.2
ATP1B1	1q24	ATPase, Na+/K+ transporting, beta 1 polypeptide	NCI-H929	8.5
ATP6AP2	Xq21	ATPase, H+ transporting, lysosomal accessory protein 2	NCI-H929	7.1
ATP6V0D1	16q22	ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d isoform 1	NCI-H929	7
ATP6V1D	14q23-q24.2	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D	NCI-H929	5.7
AZI1	17q25.3	5-azacytidine induced 1	U266, NCI-H929	6.7, 6.7
BACH	1p36.31-p36.11	brain acyl-CoA hydrolase	MM1	4.5
BAIAP2	17q25	BAI1-associated protein 2	U266	34
BAIAP3	16p13.3	BAI1-associated protein 3	MM1, U266	13.8, 15.8
BCL6	3q27	B-cell CLL/lymphoma 6 (zinc finger protein 51)	MM1, NCI-H929	5.4, 76.5
BEXL1	Xq22.1-q22.3	brain expressed X-linked-like 1	U266	5.8
BG1	15q23-q24	lipidosin	U266	27.3
BIK	22q13.31	BCL2-interacting killer (apoptosis-inducing)	MM1, NCI-H929	7.1, 7.6
BIN1	2q14	bridging integrator 1	U266	8.3
BIRC3	11q22	baculoviral IAP repeat-containing 3	MM1, NCI-H929	9.5, 5.2
BMP2K	4q21.21	BMP2 inducible kinase	MM1	20.1
BRCA2	13q12.3	breast cancer 2, early onset	MM1	11.2
BTG1	12q22	B-cell translocation gene 1, anti-proliferative	NCI-H929	5
C10orf3	10q23.33	chromosome 10 open reading frame 3	MM1	5.2
C14orf78	14q32.33	chromosome 14 open reading frame 78	NCI-H929	6.3
C19orf28	19p13.3	chromosome 19 open reading frame 28	U266	6.7
C19orf36	19p13.3	chromosome 19 open reading frame 36	U266, NCI-H929	15.5, 29.0
C1S	12p13	complement component 1, s subcomponent	U266	13.2
C20orf12	20p11.23	chromosome 20 open reading frame 12	NCI-H929	7.3
C20orf19	20pter-q11.23	chromosome 20 open reading frame 19	U266	7.2
C2orf31	2q34	chromosome 2 open reading frame 31	MM1	6
C3	19p13.3-p13.2	complement component 3	U266	8.2
C3F	12p13	putative protein similar to nessy (Drosophila)	U266	6.7
C3orf14	3p14.2	chromosome 3 open reading frame 14	U266	13.3
CACNA1G	17q22	calcium channel, voltage-dependent, alpha 1G subunit	U266, NCI-H929	7.1, 9.3
CALM1	14q24-q31	calmodulin 1 (phosphorylase kinase, delta)	NCI-H929	5.5
CAMTA1	1p36.31-p36.23	calmodulin binding transcription activator 1	U266	15.9
CCK	3p22-p21.3	cholecystokinin	U266	49
CCNA1	13q12.3-q13	cyclin A1	U266, NCI-H929	23.4, 6.2
CCNF	16p13.3	cyclin F	MM1	20
CD24	6q21	CD24 antigen (small cell lung carcinoma cluster 4 antigen)	MM1, U266, NCI-H929	27.3, 12.9, 28.0
CD9	12p13.3	CD9 antigen (p24)	U266	26.1
CDC14B	9q22.33	CDC14 cell division cycle 14 homolog B (S. cerevisiae)	U266	8.3
CDH1	16q22.1	cadherin 1, type 1, E-cadherin (epithelial)	U266	38.7
CDH19	18q22-q23	cadherin 19, type 2	NCI-H929	18.7
CDKL3	5q31	cyclin-dependent kinase-like 3	U266	7.5
CDKN1A	6p21.2	cyclin-dependent kinase inhibitor 1A (p21, Cip1)	NCI-H929	27.3
CDKN1C	11p15.5	cyclin-dependent kinase inhibitor 1C (p57, Kip2)	U266	82.5
CEL	9q34.3	carboxyl ester lipase (bile salt-stimulated lipase)	U266	22
CFH	1q32	complement factor H	NCI-H929	16.4
CGA	6q12-q21	glycoprotein hormones, alpha polypeptide	U266	34.3
CGB	19q13.32	chorionic gonadotropin, beta polypeptide	U266	8.7
CGREF1	2p23.3	cell growth regulator with EF-hand domain 1	U266	14
CNTNAP2	7q35-q36	contactin associated protein-like 2	NCI-H929	11.3
COL14A1	8q23	collagen, type XIV, alpha 1 (undulin)	MM1, NCI-H929	14.3, 5.9
COL6A2	21q22.3	collagen, type VI, alpha 2	U266	12.1
COTL1	16q24.1	coactosin-like 1 (Dictyostelium)	MM1, U266, NCI-H929	8.6, 10.6, 14.8
CRIP2	14q32.3	cysteine-rich protein 2	MM1, NCI-H929	15.9, 17.5
CRISPLD2	16q24.1	cysteine-rich secretory protein LCCL domain containing 2	U266	17.7
CSPG3	19p12	chondroitin sulfate proteoglycan 3 (neurocan)	NCI-H929	6.2
CSPG5	3p21.3	chondroitin sulfate proteoglycan 5 (neuroglycan C)	U266	7
CSRP2	12q21.1	cysteine and glycine-rich protein 2	MM1, NCI-H929	6.4, 13.8
CSTA	3q21	cystatin A (stefin A)	NCI-H929	22.8
CTH	1p31.1	cystathionase (cystathionine gamma-lyase)	NCI-H929	8.5
CTSL2	9q22.2	cathepsin L2	NCI-H929	6.6
CXCL11	4q21.2	chemokine (C-X-C motif) ligand 11	U266	10.6
CYLN2	7q11.23	cytoplasmic linker 2	U266, NCI-H929	11.9, 17.7
CYP1A1	15q22-q24	cytochrome P450, family 1, subfamily A, polypeptide 1	MM1, NCI-H929	5.8, 14.8
CYP1B1	2p21	cytochrome P450, family 1, subfamily B, polypeptide 1	MM1, NCI-H929	9.7, 9.0
CYP26B1	2p13.2	cytochrome P450, family 26, subfamily B, polypeptide 1	U266	8.9
DAZL	3p24.3	deleted in azoospermia-like	U266	18.4
DBN1	5q35.3	drebrin 1	U266	7.2
DDAH2	6p21.3	dimethylarginine dimethylaminohydrolase 2	NCI-H929	4.6
DDX4	5p15.2-p13.1	DEAD (Asp-Glu-Ala-Asp) box polypeptide 4	U266	15.5
DDX43	6q12-q13	DEAD (Asp-Glu-Ala-Asp) box polypeptide 43	U266	30.1
DHRS2	14q11.2	dehydrogenase/reductase (SDR family) member 2	MM1, U266, NCI-H929	38.3, 295.0, 96.6
DHRS8	4q22.1	dehydrogenase/reductase (SDR family) member 8	U266	6.3
DLG7	14q22.3	discs, large homolog 7 (Drosophila)	MM1	5.9
DLX2	2q32	distal-less homeo box 2	U266, NCI-H929	29.8, 8.8
DMRT1	9p24.3	doublesex and mab-3 related transcription factor 1	U266	15.3
DNAH3	16p12.3	dynein, axonemal, heavy polypeptide 3	U266	5.1
DNM3	1q24.3	dynamin 3	NCI-H929	6.3
DPEP3	16q22.1	dipeptidase 3	U266	34.2
DRE1	3q27.1	DRE1 protein	NCI-H929	15.7
DUSP1	5q34	dual specificity phosphatase 1	U266	8
DUSP2	2q11	dual specificity phosphatase 2	U266	27.5
DYRK3	1q32.1	dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3	MM1	6.6
DZIP1	13q32.1	DAZ interacting protein 1	U266	7.9
DZIP3	3q13.13	zinc finger DAZ interacting protein 3	MM1	18.2
ECAT8	19q13.11	ES cell associated transcript 8	U266	11.7
EFHC1	6p12.3	EF-hand domain (C-terminal) containing 1	NCI-H929	7
EFNB2	13q33	ephrin-B2	MM1, NCI-H929	10.0, 9.0
EGR1	5q31.1	early growth response 1	MM1, U266, NCI-H929	6.5, 5.5, 7.9
EGR2	10q21.1	early growth response 2 (Krox-20 homolog, Drosophila)	U266	9.8
EGR4	2p13	early growth response 4	U266	23.9
EHHADH	3q26.3-q28	enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase	MM1	5.3
EIF4EBP2	10q21-q22	Eukaryotic translation initiation factor 4E binding protein 2	NCI-H929	11.1
ENAH	1q42.12	enabled homolog (Drosophila)	U266	10.8
ENPP2	8q24.1	ectonucleotide pyrophosphatase/phosphodiesterase 2 (autotaxin)	MM1, NCI-H929	47.3, 96.2
EPAS1	2p21-p16	endothelial PAS domain protein 1	MM1, U266, NCI-H929	11.4, 31.7, 39.2
EPHA3	3p11.2	EPH receptor A3	MM1, NCI-H929	22.0, 23.6
ERO1LB	1q42.2-q43	ERO1-like beta (S. cerevisiae)	NCI-H929	8
FAM49A	2p24.3-p24.2	Family with sequence similarity 49, member A	MM1, U266, NCI-H929	11.4, 7.9, 20.2
FBN1	15q21.1	fibrillin 1 (Marfan syndrome)	MM1, NCI-H929	16.6, 7.7
FBP2	9q22.3	fructose-1,6-bisphosphatase 2	U266	41.7
FDXR	17q24-q25	ferredoxin reductase	U266	6.3
FER	5q21	fer (fps/fes related) tyrosine kinase (phosphoprotein NCP94)	U266	5.2
FER1L3	10q24	fer-1-like 3, myoferlin (C. elegans)	NCI-H929	21.4
FGD6	12q22	FYVE, RhoGEF and PH domain containing 6	MM1	4.4
FGFR1	8p11.2-p11.1	fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome)	NCI-H929	8.3
FGFR3	4p16.3	fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism)	U266	24.5
FGFR4	5q35.1-qter	fibroblast growth factor receptor 4	MM1, NCI-H929	4.5, 7.2
FHL1	Xq26	four and a half LIM domains 1	U266	6.6
FKBP1B	2p23.3	FK506 binding protein 1B, 12.6 kDa	U266, NCI-H929	5.2, 16.7
FLJ10178	Xq22.3	hypothetical protein FLJ10178	U266	40.6
FLJ10922	19q13.32	hypothetical protein FLJ10922	U266	22.6
FLJ12584	2q37.1	melanoma/melanocyte specific protein KU-MEL-1	MM1, NCI-H929	11.0, 7.4
FLJ14627	12q24.22	hypothetical protein FLJ14627	MM1	10.2
FLJ20130	Xq22.3	hypothetical protein FLJ20130	U266, NCI-H929	4.6, 4.8
FLJ20507	2q11.2	hypothetical protein FLJ20507	MM1	13.2
FLJ21159	4q32.1	ASAP	MM1	18.7
FLJ22833	2q32.3	hypothetical protein FLJ22833	MM1	10.6
FLNA	Xq28	filamin A, alpha (actin binding protein 280)	MM1	5.2
FLNB	3p14.3	filamin B, beta (actin binding protein 278)	MM1	9.2
FN1	2q34	fibronectin 1	MM1, U266, NCI-H929	46.0, 72.7, 40.6
FOS	14q24.3	v-fos FBJ murine osteosarcoma viral oncogene homolog	U266, NCI-H929	52.2, 22.8
FOXG1B	14q12-q13	forkhead box G1B	MM1	6.9
FSCN1	7p22	fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus)	MM1, U266, NCI-H929	84.7, 207.6, 64.6
FTCD	21q22.3	formiminotransferase cyclodeaminase	U266	26.9
FTL	19q13.3-q13.4	ferritin, light polypeptide	NCI-H929	7.8
FUCA1	1p34	fucosidase, alpha-L- 1, tissue	NCI-H929	6
G1P3	1p35	interferon, alpha-inducible protein (clone IFI-6-16)	MM1	7
G6PD	Xq28	glucose-6-phosphate dehydrogenase	MM1, NCI-H929	25.9, 14.5
GAGE1	Xp11.4-p11.2	G antigen 1	MM1, U266, NCI-H929	11.5, 26.8, 11.3
GAGE2	Xp11.23	G antigen 2	U266, NCI-H929	91.7, 14.0
GAGE3	Xp11.4-p11.2	G antigen 3	U266	21
GAGE4	Xp11.4-p11.2	G antigen 4	U266, NCI-H929	20.8, 10.8
GAGE5	Xp11.4-p11.2	G antigen 5	MM1, U266, NCI-H929	5.8, 24.5, 6.0
GAL	11q13.2	galanin	U266	12
GATA3	10p15	GATA binding protein 3	NCI-H929	22.4
GLCE	15q23	glucuronyl C5-epimerase	MM1, U266	6.6, 13.1
GLDC	9p22	glycine dehydrogenase (decarboxylating; glycine decarboxylase, glycine cleavage system protein P)	MM1, U266, NCI-H929	12.7, 5.5, 9.9
GLUL	1q31	glutamate-ammonia ligase (glutamine synthase)	U266	6.8
GLULD1	6pter-q22.33	glutamate-ammonia ligase (glutamine synthase) domain containing 1	NCI-H929	8.1
GM2A	5q31.3-q33.1	GM2 ganglioside activator	MM1, NCI-H929	25.5, 9.0
GMPR	6p23	guanosine monophosphate reductase	MM1, U266	12.2, 6.1
GNS	12q14	glucosamine (N-acetyl)-6-sulfatase (Sanfilippo disease IIID)	NCI-H929	16.2
GPM6A	4q34	glycoprotein M6A	MM1, NCI-H929	18.3, 23.2
GPSM2	1p13.3	G-protein signalling modulator 2 (AGS3-like, C. elegans)	MM1	9.5
GRN	17q21.32	granulin	NCI-H929	6.9
GSN	9q33	gelsolin (amyloidosis, Finnish type)	MM1, NCI-H929	6.8, 8.7
H1F0	22q13.1	H1 histone family, member 0	MM1, U266, NCI-H929	48.7, 6.0, 46.2
H2AFB3	Xq28	H2A histone family, member B3	U266	10.5
HABP4	9q22.3-q31	hyaluronan binding protein 4	MM1	8.4
HBA1	16p13.3	hemoglobin, alpha 1	MM1, U266, NCI-H929	70.9, 46.9, 94.8
HBA2	16p13.3	hemoglobin, alpha 2	MM1, U266, NCI-H929	57.8, 139.0, 82.6
HES1	3q28-q29	hairy and enhancer of split 1, (Drosophila)	U266	57.7
HIST1H1C	6p21.3	histone 1, H1c	MM1, NCI-H929	15.9, 16.6
HIST1H1T	6p21.3	histone 1, H1t	U266	19.1
HIST1H2AC	6p21.3	histone 1, H2ac	U266	5.7
HIST1H2AE	6p22.2-p21.1	histone 1, H2ae	MM1, U266, NCI-H929	32.5, 199.5, 68.9
HIST1H2AG	6p22.1	histone 1, H2ag	MM1, U266, NCI-H929	16.3, 8.7, 18.8
HIST1H2AI	6p22-p21.3	histone 1, H2ai	U266	7.5
HIST1H2AM	6p22-p21.3	Histone 1, H2am	U266	13.7
HIST1H2BB	6p21.3	histone 1, H2bb	U266	32
HIST1H2BC	6p21.3	histone 1, H2bc	MM1, NCI-H929	6.1, 6.1
HIST1H2BG	6p21.3	histone 1, H2bg	MM1, U266, NCI-H929	7.1, 149.8, 17.5
HIST1H2BI	6p21.3	histone 1, H2bi	U266	5.4
HIST1H3B	6p21.3	histone 1, H3b	MM1, U266	22.4, 8.5
HIST1H3D	6p21.3	histone 1, H3d	U266	27.6
HIST1H3G	6p21.3	histone 1, H3g	NCI-H929	57.7
HIST1H3H	6p22-p21.3	histone 1, H3h	MM1, U266, NCI-H929	5.5, 12.3, 21.3
HIST1H3J	6p22-p21.3	Histone 1, H3j	U266	9.1
HIST1H4B	6p21.3	histone 1, H4b	U266	10.9
HIST1H4H	6p21.3	histone 1, H4h	NCI-H929	16.4
HIST1H4K	6p22-p21.3	histone 1, H4k	U266	10.9
HIST2H2AA	1q21.2	histone 2, H2aa	MM1, U266, NCI-H929	14.4, 6.2, 33.1
HIST2H2BE	1q21-q23	histone 2, H2be	MM1, NCI-H929	12.6, 15.9
HIST2H4	1q21	histone 2, H4	NCI-H929	16.7
HIST3H2A	1q42.13	histone 3, H2a	U266	7.3
HIST3H3	1q42	histone 3, H3	U266	23.2
HK1	10q22	hexokinase 1	MM1	4.8
HLA-DPA1	6p21.3	major histocompatibility complex, class II, DP alpha 1	MM1	21.7
HLA-DPB1	6p21.3	major histocompatibility complex, class II, DP beta 1	MM1	10.2
HLA-DQA1	6p21.3	major histocompatibility complex, class II, DQ alpha 1	MM1	5.7
HLA-DRB1	6p21.3	major histocompatibility complex, class II, DR beta 1	MM1	10
HLA-DRB4	6p21.3	major histocompatibility complex, class II, DR beta 4	MM1, NCI-H929	82.3, 6.1
HN1	17q25.1	hematological and neurological expressed 1	MM1	6.4
HOXA1	7p15.3	homeo box A1	MM1, U266	7.5, 23.3
HPGD	4q34-q35	hydroxyprostaglandin dehydrogenase 15-(NAD)	MM1	19.8
HPSE	4q21.3	heparanase	MM1, NCI-H929	12.0, 18.5
HSD17B1	17q11-q21	hydroxysteroid (17-beta) dehydrogenase 1	U266	15.2
HSPA1A	6p21.3	heat shock 70kDa protein 1A	U266, NCI-H929	57.5, 8.7
HSPA2	14q24.1	heat shock 70kDa protein 2	MM1, U266, NCI-H929	12.3, 9.6, 26.1
HUMPPA	17q25.1	paraneoplastic antigen	MM1, U266	26.7, 14.0
ID1	20q11	inhibitor of DNA binding 1, dominant negative helix-loop-helix protein	U266	5.7
ID2	2p25	inhibitor of DNA binding 2, dominant negative helix-loop-helix protein	U266, NCI-H929	14.9, 4.5
IER3	6p21.3	immediate early response 3	U266, NCI-H929	7.3, 6.4
IFI27	14q32	interferon, alpha-inducible protein 27	MM1, U266, NCI-H929	6.5, 6.0, 9.6
IFIT1	10q25-q26	interferon-induced protein with tetratricopeptide repeats 1	MM1, NCI-H929	29.4, 40.0
IGFBP3	7p13-p12	insulin-like growth factor binding protein 3	MM1, NCI-H929	9.0, 19.3
IL13RA1	Xq24	interleukin 13 receptor, alpha 1	U266	26
IL15	4q31	interleukin 15	MM1, U266, NCI-H929	7.3, 7.2, 11.4
ING1	13q34	inhibitor of growth family, member 1	U266	10.9
ITGA6	2q31.1	integrin, alpha 6	U266	16.3
ITGA7	12q13	integrin, alpha 7	MM1, U266, NCI-H929	40.7, 15.9, 13.3
ITGBL1	13q33	integrin, beta-like 1 (with EGF-like repeat domains)	MM1, NCI-H929	23.2, 41.5
ITSN1	21q22.1-q22.2	Intersectin 1 (SH3 domain protein)	U266	7.4
JAG1	20p12.1-p11.23	jagged 1 (Alagille syndrome)	U266	4.8
JAG2	14q32	jagged 2	U266	13.4
JARID1B	1q32.1	Jumonji, AT rich interactive domain 1B (RBP2-like)	NCI-H929	8.4
JUP	17q21	junction plakoglobin	U266	13.1
KATNB1	16q13	katanin p80 (WD repeat containing) subunit B 1	NCI-H929	7.7
KCNN2	5q22.3	potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2	NCI-H929	12.3
KCTD12	13q22.3	potassium channel tetramerisation domain containing 12	U266	5.7
KHK	2p23.3-p23.2	ketohexokinase (fructokinase)	NCI-H929	6.8
KIAA0404	11q13.1	KIAA0404 protein	U266	4.3
KIAA0415	7p22.2	KIAA0415 gene product	NCI-H929	8.9
KIAA0446	1q22	KIAA0446 gene product	MM1	5.8
KIAA0513	16q24.1	KIAA0513	U266, NCI-H929	7.1, 8.3
KIAA0913	10q22.2	KIAA0913	NCI-H929	26.9
KIAA1109	4q27	KIAA1109	U266	5.2
KIAA1117	6q15	KIAA1117	MM1	8
KIF4A	Xq13.1	kinesin family member 4A	MM1	5.3
KIF5C	2q23.1	kinesin family member 5C	U266	9.1
KLF2	19p13.13-p13.11	Kruppel-like factor 2 (lung)	NCI-H929	8.6
KRT18	12q13	keratin 18	U266	7.6
L1CAM	Xq28	L1 cell adhesion molecule	MM1, NCI-H929	12.8, 7.3
LAMP3	3q26.3-q27	lysosomal-associated membrane protein 3	MM1, NCI-H929	9.2, 9.8
LHX2	9q33-q34.1	LIM homeobox 2	MM1	4.9
LIFR	5p13-p12	leukemia inhibitory factor receptor	U266, NCI-H929	11.5, 21.0
LONP	16q12.1	Peroxisomal lon protease	U266	8.4
LPPR2	19p13.2	lipid phosphate phosphatase-related protein type 2	MM1	10.3
MAFB	20q11.2-q13.1	v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)	NCI-H929	35.5
MAGEA11	Xq28	melanoma antigen family A, 11	U266	7.8
MAGEA3	Xq28	melanoma antigen family A, 3	MM1, NCI-H929	19.8, 31.1
MAGEA4	Xq28	melanoma antigen family A, 4	MM1	6.2
MAGEA6	Xq28	melanoma antigen family A, 6	MM1, NCI-H929	9.7, 21.9
MAGEA9	Xq28	melanoma antigen family A, 9	NCI-H929	6.4
MAGEB2	Xp21.3	melanoma antigen family B, 2	NCI-H929	5.5
MAGEC1	Xq26	melanoma antigen family C, 1	NCI-H929	9.2
MAPK8IP1	11p12-p11.2	mitogen-activated protein kinase 8 interacting protein 1	U266	8.6
MAPRE3	2p23.3-p23.1	microtubule-associated protein, RP/EB family, member 3	U266	13.9
MAPT	17q21.1	microtubule-associated protein tau	U266	7.1
MARCKSL1	1p35.1	MARCKS-like 1	MM1, U266	6.6, 10.7
MEF2C	5q14	MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C)	MM1	6.6
MET	7q31	met proto-oncogene (hepatocyte growth factor receptor)	MM1	11
MGC14376	17p13.3	hypothetical protein MGC14376	NCI-H929	6.9
MGST3	1q23	microsomal glutathione S-transferase 3	MM1, NCI-H929	9.1, 16.6
MICAL2	11p15.3	microtubule associated monoxygenase, calponin and LIM domain containing 2	U266	6.7
MICAL-L2	7p22.3	MICAL-like 2	MM1, U266	13.5, 14.7
MLF1	3q25.1	myeloid leukemia factor 1	MM1, NCI-H929	4.8, 5.6
MSH5	6p21.3	mutS homolog 5 (E. coli)	NCI-H929	5.9
MSX1	4p16.3-p16.1	msh homeo box homolog 1 (Drosophila)	U266	19.9
MT1E	16q13	metallothionein 1E (functional)	MM1	10
MT1H	16q13	metallothionein 1H	NCI-H929	8.5
MT1X	16q13	metallothionein 1X	MM1, U266, NCI-H929	7.3, 6.1, 5.7
MT2A	16q13	metallothionein 2A	MM1, NCI-H929	7.9, 10.7
MYBL1	8q22	v-myb myeloblastosis viral oncogene homolog (avian)-like 1	MM1	5.3
MYCN	2p24.1	v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)	U266	9.4
MYO9B	19p13.1	myosin IXB	MM1, U266	11.2, 10.3
NAB2	12q13.3-q14.1	NGFI-A binding protein 2 (EGR1 binding protein 2)	U266	16.7
NAP1L3	Xq21.3-q22	nucleosome assembly protein 1-like 3	NCI-H929	4.9
NAT1	8p23.1-p21.3	N-acetyltransferase 1 (arylamine N-acetyltransferase)	NCI-H929	5.2
NCAM1	11q23.1	neural cell adhesion molecule 1	MM1, NCI-H929	5.2, 19.7
NEDD9	6p25-p24	neural precursor cell expressed, developmentally down-regulated 9	MM1, NCI-H929	17.4, 6.8
NEFL	8p21	neurofilament, light polypeptide 68kDa	U266	6.9
NEU1	6p21.3	sialidase 1 (lysosomal sialidase)	NCI-H929	13.7
NFYA	6p21.3	nuclear transcription factor Y, alpha	NCI-H929	17.1
NGFRAP1	Xq22.2	nerve growth factor receptor (TNFRSF16) associated protein 1	U266	9.4
NPAL3	1p36.12-p35.1	NIPA-like domain containing 3	NCI-H929	9.5
NPTX2	7q21.3-q22.1	neuronal pentraxin II	U266	59.7
NR1H4	12q23.1	nuclear receptor subfamily 1, group H, member 4	U266	7.2
NR4A1	12q13	nuclear receptor subfamily 4, group A, member 1	U266	11.2
NR4A2	2q22-q23	nuclear receptor subfamily 4, group A, member 2	U266, NCI-H929	8.9, 14.1
NRGN	11q24	neurogranin (protein kinase C substrate, RC3)	MM1, U266	16.3, 6.2
NRXN1	2p16.3	neurexin 1	NCI-H929	11.4
NTS	12q21	neurotensin	NCI-H929	13.2
NUDT11	Xp11.22	nudix (nucleoside diphosphate linked moiety X)-type motif 11	U266	12.5
NUP93	16q13	nucleoporin 93kDa	MM1	6.2
NXN	17p13.3	nucleoredoxin	MM1	5.7
OAT	10q26	ornithine aminotransferase (gyrate atrophy)	MM1, U266	4.8, 7.5
ODC1	2p25	ornithine decarboxylase 1	MM1	4.6
ODZ1	Xq25	odz, odd Oz/ten-m homolog 1(Drosophila)	MM1, NCI-H929	14.0, 9.9
OGDHL	10q11.23	oxoglutarate dehydrogenase-like	U266	17.6
ORC5L	7q22.1	origin recognition complex, subunit 5-like (yeast)	U266	23.8
PAEP	9q34	progestagen-associated endometrial protein	U266	18.9
PCDH9	13q14.3-q21.1	protocadherin 9	NCI-H929	9.4
PCLO	7q11.23-q21.3	Piccolo (presynaptic cytomatrix protein)	MM1	7
PCTK3	1q31-q32	PCTAIRE protein kinase 3	U266	7.1
PDGFRL	8p22-p21.3	platelet-derived growth factor receptor-like	MM1, U266, NCI-H929	10.8, 6.1, 7.3
PDLIM5	4q22	PDZ and LIM domain 5	MM1	15.1
PEG10	7q21	paternally expressed 10	MM1, NCI-H929	7.1, 11.5
PFKFB3	10p14-p15	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3	U266	5
PFN2	3q25.1-q25.2	profilin 2	U266	7.3
PGBD5	1q42.13	piggyBac transposable element derived 5	NCI-H929	13.6
PGF	14q24-q31	placental growth factor, vascular endothelial growth factor-related protein	U266	7.5
PHLDA2	11p15.5	pleckstrin homology-like domain, family A, member 2	U266	31.3
PIGV	1p36.11	phosphatidylinositol glycan, class V	NCI-H929	11.9
PIK3CD	1p36.2	phosphoinositide-3-kinase, catalytic, delta polypeptide	MM1, NCI-H929	23.3, 6.0
PLEC1	8q24	plectin 1, intermediate filament binding protein 500kDa	U266	20.6
PLK2	5q12.1-q13.2	polo-like kinase 2 (Drosophila)	MM1, U266, NCI-H929	6.5, 15.6, 27.8
PLS1	3q23	plastin 1 (I isoform)	MM1	5.1
PLXNB3	Xq28	plexin B3	U266	12
POLR2L	11p15	polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa	MM1	4.5
POR	7q11.2	P450 (cytochrome) oxidoreductase	U266	5.9
PPARD	6p21.2-p21.1	peroxisome proliferative activated receptor, delta	NCI-H929	8.6
PPL	16p13.3	periplakin	MM1, U266, NCI-H929	23.3, 49.6, 27.4
PPM1E	17q23.2	protein phosphatase 1E (PP2C domain containing)	U266	18.5
PPP2R3B	Xp22.33; Yp11.3	protein phosphatase 2 (formerly 2A), regulatory subunit B, beta	U266	11.4
PRKAR2B	7q22	protein kinase, cAMP-dependent, regulatory, type II, beta	MM1, U266, NCI-H929	6.6, 9.6, 6.4
PRKCB1	16p11.2	protein kinase C, beta 1	MM1, NCI-H929	4.6, 12.3
PRPH	12q12-q13	peripherin	U266	14.3
PRSS2	7q34	protease, serine, 2 (trypsin 2)	U266	5.7
PSAP	10q21-q22	prosaposin (variant Gaucher disease and variant metachromatic leukodystrophy)	NCI-H929	5.2
PTD015	11q13.5	PTD015 protein	NCI-H929	5.7
PTGER4	5p13.1	prostaglandin E receptor 4 (subtype EP4)	MM1	12.1
PTK2	8q24-qter	PTK2 protein tyrosine kinase 2	MM1	17.4
PYY	17q21.1	peptide YY	U266	35.9
RAB13	1q21.2	RAB13, member RAS oncogene family	U266	9.4
RAB6IP1	11p15.4	RAB6 interacting protein 1	U266	15.8
RAI2	Xp22	retinoic acid induced 2	NCI-H929	11.2
RASGRP2	11q13	RAS guanyl releasing protein 2 (calcium and DAG-regulated)	U266	7.7
RBM9	22q13.1	RNA binding motif protein 9	U266	6.9
RCN3	19q13.33	reticulocalbin 3, EF-hand calcium binding domain	MM1	24.8
RHCE	1p36.11	Rhesus blood group, CcEe antigens	U266, NCI-H929	8.3, 10.8
RHOB	2p24	ras homolog gene family, member B	U266	14.9
RIS1	3p21.3	Ras-induced senescence 1	MM1, U266	19.1, 22.0
RNF128	Xq22.3	ring finger protein 128	MM1, NCI-H929	4.3, 10.6
RNU2	17q12-q21	RNA, U2 small nuclear	U266, NCI-H929	27.6, 21.1
	6p25	tubulin, beta polypeptide paralog	U266	39.8
RPIB9	7q21.12	Rap2-binding protein 9	U266, NCI-H929	29.7, 15.0
RPS20	8q12	Ribosomal protein S20	NCI-H929	12.3
RPS6KA2	6q27	ribosomal protein S6 kinase, 90kDa, polypeptide 2	NCI-H929	8.3
RRAD	16q22	Ras-related associated with diabetes	U266	8.5
RRAS	19q13.3-qter	related RAS viral (r-ras) oncogene homolog	MM1, NCI-H929	4.9, 6.8
RRBP1	20p12	Ribosome binding protein 1 homolog 180kDa (dog)	U266	8.7
RTN2	19q13.32	reticulon 2	MM1, NCI-H929	6.4, 7.2
S100A4	1q21	S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog)	MM1	12.9
SART2	6q22	squamous cell carcinoma antigen recognized by T cells 2	NCI-H929	5.4
SAT	Xp22.1	spermidine/spermine N1-acetyltransferase	U266, NCI-H929	11.8, 115.6
SCP2	1p32	Sterol carrier protein 2	U266	12
SDC4	20q12	syndecan 4 (amphiglycan, ryudocan)	MM1	6.4
SEPP1	5q31	selenoprotein P, plasma, 1	MM1	5.1
4-Sep	17q22-q23	septin 4	MM1, NCI-H929	4.9, 8.5
SERPINB5	18q21.3	serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 5	U266	20
SERPINE2	2q33-q35	serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2	MM1	4.5
SERPINF1	17p13.1	serine (or cysteine) proteinase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1	U266	10.2
SERPINI1	3q26.1	serine (or cysteine) proteinase inhibitor, clade I (neuroserpin), member 1	MM1, U266, NCI-H929	7.6, 11.5, 17.9
SFXN3	10q24.32	sideroflexin 3	U266	9
SGKL	8q12.3-8q13.1	serum/glucocorticoid regulated kinase-like	NCI-H929	70.4
SH3BGR	21q22.3	SH3 domain binding glutamic acid-rich protein	NCI-H929	13.9
SH3GL3	15q24	SH3-domain GRB2-like 3	U266, NCI-H929	10.7, 7.4
SILV	12q13-q14	silver homolog (mouse)	MM1, NCI-H929	10.0, 7.5
SLC12A8	3q21.2	solute carrier family 12 (potassium/chloride transporters), member 8	MM1, NCI-H929	9.7, 15.4
SLC16A3	17q25	solute carrier family 16 (monocarboxylic acid transporters), member 3	U266	11.6
SLC16A4	1p13.3	solute carrier family 16 (monocarboxylic acid transporters), member 4	U266	54.6
SLC17A7	19q13	solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7	MM1, NCI-H929	10.5, 12.7
SLC25A31	4q28.1	solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31	U266	6.2
SLC4A8	12q13	solute carrier family 4, sodium bicarbonate cotransporter, member 8	MM1	8.1
SLC6A8	Xq28	solute carrier family 6 (neurotransmitter transporter, creatine), member 8	MM1, U266	13.3, 26.3
SLC9A1	1p36.1-p35	solute carrier family 9 (sodium/hydrogen exchanger), isoform 1 (antiporter, Na+/H+, amiloride sensitive)	NCI-H929	10.1
SMARCD3	7q35-q36	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3	NCI-H929	6.7
SMPD3	16q22.1	sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)	U266	7.6
SNAI1	20q13.1-q13.2	snail homolog 1 (Drosophila)	U266	17.7
SNAP23	15q15.1	synaptosomal-associated protein, 23kDa	NCI-H929	17.7
SNAP25	20p12-p11.2	synaptosomal-associated protein, 25kDa	MM1	9.5
SORBS1	10q23.3-q24.1	sorbin and SH3 domain containing 1	NCI-H929	53.2
SORT1	1p21.3-p13.1|1p21.3-p13.1	sortilin 1	NCI-H929	12.1
SOX4	6p22.3	SRY (sex determining region Y)-box 4	U266	33.7
SPAG6	10p12.2	sperm associated antigen 6	U266	10.3
SPAG9	17q21.33	sperm associated antigen 9	MM1, U266, NCI-H929	4.6, 4.6, 4.4
SPIB	19q13.3-q13.4	Spi-B transcription factor (Spi-1/PU.1 related)	MM1	12.7
SPINK2	4q12	serine protease inhibitor, Kazal type 2 (acrosin-trypsin inhibitor)	MM1, NCI-H929	9.0, 7.5
SPP1	4q21-q25	secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1)	MM1, NCI-H929	5.0, 10.6
SPTLC2	14q24.3-q31	serine palmitoyltransferase, long chain base subunit 2	NCI-H929	9.1
SQSTM1	5q35	sequestosome 1	NCI-H929	8.7
SSX1	Xp11.23-p11.22	synovial sarcoma, X breakpoint 1	NCI-H929	17
SSX2	Xp11.23-p11.22	synovial sarcoma, X breakpoint 2	MM1, NCI-H929	20.4, 21.2
SSX3	Xp11.23	synovial sarcoma, X breakpoint 3	NCI-H929	11
STAT1	2q32.2	signal transducer and activator of transcription 1, 91kDa	NCI-H929	8.6
STAT3	17q21.31	signal transducer and activator of transcription 3 (acute-phase response factor)	MM1	4.6
SWAP70	11p15	SWAP-70 protein	NCI-H929	7.4
SYN1	Xp11.23	synapsin I	MM1, NCI-H929	24.9, 66.9
SYT1	Xp11.23	synapsin I	NCI-H929	66.9
SYT11	1q21.2	synaptotagmin XI	NCI-H929	13.9
TAC1	7q21-q22	tachykinin, precursor 1	U266	23.9
TADA3L	3p25.3	transcriptional adaptor 3 (NGG1 homolog, yeast)-like	MM1	8.3
TAOK3	12q	TAO kinase 3	U266, NCI-H929	6.1, 4.8
TFAP2C	20q13.2	transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)	NCI-H929	6.1
TFEC	7q31.2	transcription factor EC	U266	6.1
TFPI	2q31-q32.1	Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)	MM1, NCI-H929	6.7, 64.9
TFPI2	7q22	tissue factor pathway inhibitor 2	U266	16
TFRC	3q29	transferrin receptor (p90, CD71)	MM1	5.4
TIMP1	Xp11.3-p11.23	tissue inhibitor of metalloproteinase 1 (erythroid potentiating activity, collagenase inhibitor)	U266	5
TIMP3	22q12.1-q13.2|22q12.3	tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, pseudoinflammatory)	U266	17.1
TKTL1	Xq28	transketolase-like 1	MM1, U266, NCI-H929	147.4, 195.8, 210.0
TLE4	9q21.31	transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila)	MM1	6.5
TLN2	15q15-q21	talin 2	U266	9
TM4SF13	7p21.1	Tetraspanin 13	MM1, NCI-H929	6.4, 23.1
TMEM47	Xp11.4	transmembrane protein 47	NCI-H929	12.2
TMOD1	9q22.3	tropomodulin 1	U266	20.3
TMSL8	Xq21.33-q22.3	thymosin-like 8	U266	5.9
TNRC9	16q12.1	trinucleotide repeat containing 9	MM1, NCI-H929	18.8, 29.3
TOP2A	17q21-q22	topoisomerase (DNA) II alpha 170kDa	MM1	6.1
TPM1	15q22.1	tropomyosin 1 (alpha)	U266	6.4
TRIP6	7q22	thyroid hormone receptor interactor 6	U266	13.8
TROAP	12q13.12	trophinin associated protein (tastin)	MM1	4.4
TSPAN12	7q31.31	tetraspanin 12	NCI-H929	8.2
TST	22q13.1	thiosulfate sulfurtransferase (rhodanese)	MM1, U266	7.0, 11.0
TTLL1	22q13.1	tubulin tyrosine ligase-like family, member 1	NCI-H929	7.5
TUBA3	12q12-12q14.3	tubulin, alpha 3	MM1	7.2
TUBB2	6p25	tubulin, beta 2	MM1, U266, NCI-H929	11.9, 37.4, 14.4
TUBB3	16q24.3	tubulin, beta 3	MM1, NCI-H929	5.2, 4.9
TUBB4	19p13.3	tubulin, beta 4	MM1	5.3
TUBB6	18p11.21	tubulin, beta 6	U266	5.1
TUBG1	17q21	tubulin, gamma 1	MM1	5.6
TUFT1	1q21	tuftelin 1	NCI-H929	12.6
TULP3	12p13.3	tubby like protein 3	MM1	6
TXNIP	1q21.1	thioredoxin interacting protein	MM1, NCI-H929	12.4, 17.7
TXNRD3	3p13-q13.33	thioredoxin reductase 3	U266	15.4
UBD	6p21.3	ubiquitin D	MM1	15.8
UBE2S	19q13.43	ubiquitin-conjugating enzyme E2S	MM1	5
ULBP2	6q25	UL16 binding protein 2	U266	15.4
UNC119	17q11.2	unc-119 homolog (C. elegans)	U266	11.8
VCX	Xp22	variable charge, X-linked	NCI-H929	6.1
WASF1	6q21-q22	WAS protein family, member 1	U266	5.4
WBP5	Xq22.2	WW domain binding protein 5	U266	6
WDR7	18q21.1-q22	WD repeat domain 7	MM1	5.5
WIG1	3q26.3-q27	p53 target zinc finger protein	NCI-H929	5.9
ZCCHC14	16q24.2	zinc finger, CCHC domain containing 14	NCI-H929	4.5
ZNF10	12q24.33	zinc finger protein 10	NCI-H929	9.3
ZNF238	1q44-qter	zinc finger protein 238	U266	5.3
ZNF297B	9p24.1-q22.33	zinc finger protein 297B	NCI-H929	7
ZNF556	19p13.3	zinc finger protein 556	U266	8.9
ZNF557	19p13.2	zinc finger protein 557	NCI-H929	9.2
ZYG11BL	9q34.11	zyg-11 homolog B (C. elegans)-like	U266, NCI-H929	8.5, 14.1
